The Effect of Macrolide Resistance on the Presentation and Outcome of Patients Hospitalized forStreptococcus pneumoniaePneumonia

β-Lactam Monotherapy vs β-Lactam–Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia

(2014) Nicolas Garin et al.   JAMA Internal Medicine

Macrolides and Mortality in Critically Ill Patients With Community-Acquired Pneumonia

(2013) Wendy I. Sligl et al.   CRITICAL CARE MEDICINE

Macrolide-Based Regimens and Mortality in Hospitalized Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis

(2012) Leyla Asadi et al.   CLINICAL INFECTIOUS DISEASES

Acute Respiratory Distress Syndrome

(2012)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Epidemiology, Antibiotic Therapy, and Clinical Outcomes in Health Care-Associated Pneumonia: A UK Cohort Study

(2011) J. D. Chalmers et al.   CLINICAL INFECTIOUS DISEASES

Guideline adherence and macrolides reduced mortality in outpatients with pneumonia

(2011) Leyla Asadi et al.   RESPIRATORY MEDICINE

Combination antibiotic therapy for community-acquired pneumonia

(2011) Jesus Caballero et al.   Annals of Intensive Care

Global and Local Epidemiology of Community-Acquired Pneumonia: The Experience of the CAPNETZ Network

(2009) Tobias Welte et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia

(2008) M. I. Restrepo et al.   EUROPEAN RESPIRATORY JOURNAL

Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators

(2008) Evangelos J. Giamarellos-Bourboulis   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS